Third US Settlement Secured In Eylea Biosimilar Battle As Formycon Strikes Deal

Formycon/Valorum’s Ahzantive Joins Growing List Of Settled Eylea Biosimilars In US

(Shutterstock)

More from Legal & IP

More from Generics Bulletin